window-to-japan.eu
  • Home
  • News
  • News of the month
  • Searches and Archives
  • Downloads
Select Page

RIKEN forms 34th venture company “TransSine Technologies”, technology base is promotion of protein synthesis by non-coding RNA

Oct 31, 2012

The scientific base of the company is centered in RIKEN’s omics center, Yokohama, around Piero Carninci’s team, in collaboration with the International School of Advanced Studies, Trieste. Nikkei Biotech, Oct. 31, 2012

Taisho Pharmaceutical’s sales of its health food for fat-control, Livita, reached 4 billion Yen in 6 months

Oct 31, 2012

Livita “Self-care” products, https://www.taisho.co.jp/livita/, directed against metabolic syndrome and related diseases, are under FOSHU labeling. Fat care” is a food for specified health use suitable for suppression of body fat absorption in the small intestine...

Takeda Pharmaceuticals applies in Japan for manufacturing and sales of Cetilistat, a gastric lipase inhibitor to be sold as an antiobesic drug

Oct 30, 2012

Takeda has applied jointly with Netherland’s Norgine Co. which owns all rights on this compound. Takeda Pharmaceuticals press release, Oct. 30, 2012

Kainos begins marketing of PCR-based kit for Clostridium perfringens, a food-borne pathogen

Oct 30, 2012

Detection limit is 10 e5 CFUs Kainos press release, Oct. 25, 2010

Consumer Agency adds 6 new FOSHU items, including “resistant starch”-containing products from Matsutani Chemical Industry

Oct 29, 2012

After the decision of the Consumer Agency on Oct. 24, total FOSHU agents are now 1019 (permitted) plus 1 (recognized). An interesting new area are products such as soba containing “resistant starch”, as offered by Matsutani Chemical Industry with claims of reducing...
« Older Entries

Archives

  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • February 2021
  • January 2021
  • September 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • October 2011
  • May 2011
  • April 2011
  • February 2011
  • January 2011
  • November 2010
  • October 2010
  • August 2010
  • About us…
  • Contact
  • Imprint
  • Privacy